Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), discusses the development process for the section of ADA guidelines that touches on chronic kidney disease (CKD) management in patients with diabetes.
Robert Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), discusses how the ADA developed section 11 of its new guidelines, which focus on the management of chronic kidney disease in patients with diabetes.
Transcript:
In recent years, the ADA has taken a comprehensive approach, working with other professional societies on guidelines in cardiovascular and renal care. Is the new section 11 an outgrowth of those conversations?
The American Diabetes Association works with a number of other societies for various sections of our standards of care. What we are very careful about doing is the makeup of our professional practice committee that is the group of individuals that develop our standards of care. And what we do is we have a broad-scale multidisciplinary, multiple-professional group—so, different types of professionals and specialists. For example, for the kidney section, we had nephrologists on the group that helped to guide these standards along with the discussion in the broader professional practice committee.
Highlighting Interconnected Pathways, Emerging Therapies in CKD and HF
September 10th 2025As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways are one of the most promising strategies to alter the trajectory of these diseases.
Read More
Prevention, Early Intervention Highlighted in Updated High Blood Pressure Guidelines
September 4th 2025A new joint guideline from the American Heart Association and the American College of Cardiology emphasizes early treatment, close perinatal blood pressure monitoring, and incorporating the PREVENT risk calculator to personalize care.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen